期刊文献+

替莫唑胺类抗肿瘤药物的研究进展 被引量:2

Progress on the Antitumour Drag:Temozolomide
下载PDF
导出
摘要 综述了替莫唑胺作用机理、给药方式、合成方法、衍生物的合成及生物活性,对其合成方法和衍生物的生物活性进行分析比较发现,5-重氮基咪唑-4-甲酰胺与异氰酸甲酯反应是较好的合成替莫唑胺方法,8-位酰胺类衍生物有较好的肿瘤抑制作用。 The action mechanism, administral approaches, synthesis methods and biological activity of temozolomide derivatives were summarized in this article. It was found by comparison that synthesis of temozolomide from the reaction of 5-diazoimidazole -4-carboxamide with methyl isocyanatewas was a good way, and 8-carboxamide derivative of temozomide had the higher inhibitory activity against tumour.
出处 《精细化工中间体》 CAS 2008年第3期1-5,共5页 Fine Chemical Intermediates
基金 贵州省科技厅资助项目(黔科合NY字[2006]3041)
关键词 替莫唑胺 作用机理 合成方法 衍生物 生物活性 temozolomide activity mechanism synthesis derivative biological activity
  • 相关文献

参考文献19

二级参考文献45

  • 1何权瀛.支气管哮喘治疗的准则和药物治疗现状及未来战略[J].中国医药导刊,1999,1(1):35-38. 被引量:2
  • 2Wong ET, Hess KR, Gleason MJ, et al.Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase Ⅱ clinical trials. J Clin Oncol, 1999,17 ( 8 ) :2572-2578. 被引量:1
  • 3Yung WK, Prados MD, Yaya Tur R, et al. Multicenter phase Ⅱ trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol, 1999,17(9) :2762-2771. 被引量:1
  • 4Yung WK, Albright RE, Olson J, et al. A phase Ⅱ study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer,2000,83 ( 5 ) :588-5893. 被引量:1
  • 5Wick W, Steinbach JP, Kuker WM, et al. One week on/one week off:a novel active regimen of temozolomide for recurrent glioblastoma. Neurology,2004,62 ( 11 ) :2113- 2115. 被引量:1
  • 6Groves MD, Puduvalli VK, Hess KR, et al. Phase Ⅱ trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. J Clin Oncol, 2002,20(5) :1383-1388. 被引量:1
  • 7Jaeckle KA, Hess KR, Yung WK, et al. Phase Ⅱ evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. J Clin Oncol,2003,21 (12) :2305-2311. 被引量:1
  • 8Silvani A, Eoli M, Salmaggi A, et al. Phase Ⅱ trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. J Neurooncol, 2004,66(1-2) :203-208. 被引量:1
  • 9Brandes AA, Basso U, Reni M, et al. First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase Ⅱ study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. J Clin Oncol,2004,22 ( 9 ) : 1598-1604. 被引量:1
  • 10Butowski N, Prados MD, Lamborn KR,et al. A phase Ⅱ study of concurrent temozolomide and cis-retinoic acid with radiation for aduh patients with newly diagnosed supratentorial glioblastoma. Int J Radiat Oncol Biol Phys ,2005,61 ( 5 ) : 1454-1459. 被引量:1

共引文献30

同被引文献34

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部